Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Article
PubMed
Google Scholar
Perez-Moreno P, Brambilla E, Thomas R, Soria J. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res. 2012;18(9):2443–51.
Article
CAS
PubMed
Google Scholar
Zhou H, Zhang H, Shi M, Wang J, Huang Z, Shi J. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Int Immunopharmacol. 2020;88: 106856.
Article
CAS
PubMed
Google Scholar
Thorsteinsson H, Alexandersson A, Oskarsdottir GN, Skuladottir R, Isaksson HJ, Jonsson S, et al. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland. J Thorac Oncol. 2012;7(7):1164–9.
Article
PubMed
Google Scholar
Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519–25.
Article
CAS
Google Scholar
Kris MG, Johnson BE, Berry LD, Kwiatkowski DJ, Iafrate AJ, Wistuba II, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311(19):1998.
Article
PubMed
PubMed Central
CAS
Google Scholar
Shtivelman E, Hensing T, Simon GR, Dennis PA, Otterson GA, Bueno R, et al. Molecular pathways and therapeutic targets in lung cancer. Oncotarget. 2014;5(6):1392–433.
Article
PubMed
PubMed Central
Google Scholar
Song X, Zhao C, Jiang L, Lin S, Bi J, Wei Q, et al. High PITX1 expression in lung adenocarcinoma patients is associated with DNA methylation and poor prognosis. Pathol Res Pract. 2018;214(12):2046–53.
Article
CAS
PubMed
Google Scholar
Paik PK, Pillai RN, Lathan CS, Velasco SA, Papadimitrakopoulou V. New treatment options in advanced squamous cell lung cancer. Am Soc Clin Oncol Educ Book. 2019;39(39):e198-206.
Article
PubMed
Google Scholar
Darvin P, Toor SM, Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50(12):1–11.
Article
PubMed
CAS
Google Scholar
Doroshow DB, Sanmamed MF, Hastings K, Politi K, Rimm DL, Chen L, et al. Immunotherapy in non-small cell lung cancer: facts and hopes. Clin Cancer Res. 2019;25(15):4592–602.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang F, Wang JF, Wang Y, Liu B, Molina JR. Comparative analysis of predictive biomarkers for PD-1/PD-L1 inhibitors in cancers: developments and challenges. Cancers. 2022;14(1):109.
Article
CAS
Google Scholar
Riaz N, Havel JJ, Makarov V, Desrichard A, Urba WJ, Sims JS, et al. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell. 2017;171(4):934–49.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Lin X, Sun D. A narrative review of prognosis prediction models for non-small cell lung cancer: what kind of predictors should be selected and how to improve models? Ann Transl Med. 2021;9(20):1597.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu Y, Yang L, Zhang L, Zheng X, Xu H, Wang K, et al. Identification of a four-gene signature associated with the prognosis prediction of lung adenocarcinoma based on integrated bioinformatics analysis. Genes-Basel. 2022;13(2):238.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang L, Wu Y, Xu H, Zhang J, Zheng X, Zhang L, et al. Identification and validation of a novel six-lncRNA-based prognostic model for lung adenocarcinoma. Front Oncol. 2022;11: 775583.
Article
PubMed
PubMed Central
Google Scholar
Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinform. 2010;11(1):367.
Article
CAS
Google Scholar
Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B (Methodol). 1996;58(1):267–88.
Google Scholar
Frankish A, Diekhans M, Jungreis I, Lagarde J, Loveland JE, Mudge JM, et al. Gencode 2021. Nucleic Acids Res. 2021;49(D1):D916–23.
Article
CAS
PubMed
Google Scholar
Cho J, Hong MH, Ha S, Kim Y, Cho BC, Lee I, et al. Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer. Exp Mol Med. 2020;52(9):1550–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jung H, Kim HS, Kim JY, Sun J, Ahn JS, Ahn M, et al. DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nat Commun. 2019;10(1):4278.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kim JY, Choi JK, Jung H. Genome-wide methylation patterns predict clinical benefit of immunotherapy in lung cancer. Clin Epigenet. 2020;12(1):119.
Article
CAS
Google Scholar
Jia Q, Wu W, Wang Y, Alexander PB, Sun C, Gong Z, et al. Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 2018;9(1):5361.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14(1):7.
Article
Google Scholar
Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinform. 2010;11:367.
Article
CAS
Google Scholar
Krijthe JH. Rtsne: T-distributed stochastic neighbor embedding using barnes-hut implementation. R package version 0.15. 2015.
R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021.
Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3): 100141.
CAS
PubMed
PubMed Central
Google Scholar
Therneau T. A package for survival analysis in R. R package version 3.3-1. 2022.
Alboukadel Kassambara MKAP. Survminer: drawing survival curves using 'ggplot2'. R package version 0.4.9. 2021.
Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
Article
PubMed
PubMed Central
Google Scholar
Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for Cox’s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1–13.
Article
PubMed
PubMed Central
Google Scholar
Frank E Harrell Jr. rms: Regression Modeling Strategies. R package version 6.2-0. 2021.
J.J. Allaire, Christopher Gandrud, Kenton Russell, CJ Yetman. networkD3: D3 JavaScript network graphs from R. R package version 0.4. 2017.
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12(1):77.
Article
Google Scholar
Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2012;41(D1):D955–61.
Article
PubMed
PubMed Central
CAS
Google Scholar
Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612.
Article
PubMed
CAS
Google Scholar
Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248–62.
Article
CAS
PubMed
Google Scholar
Hu J, Yu A, Othmane B, Qiu D, Li H, Li C, et al. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. Theranostics. 2021;11(7):3089–108.
Article
CAS
PubMed
PubMed Central
Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2016.
Book
Google Scholar
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.
Article
PubMed
PubMed Central
Google Scholar
Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, et al. Survival patterns in lung and pleural cancer in Europe 1999–2007: results from the EUROCARE-5 study. Eur J Cancer. 2015;51(15):2242–53.
Article
PubMed
Google Scholar
Garon EB, Hellmann MD, Rizvi NA, Carcereny E, Leighl NB, Ahn M, et al. Five-year overall survival for patients with advanced non-small-cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study. J Clin Oncol. 2019;37(28):2518–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gettinger S, Horn L, Jackman D, Spigel D, Antonia S, Hellmann M, et al. Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer: results from the CA209-003 study. J Clin Oncol. 2018;36(17):1675–84.
Article
CAS
PubMed
Google Scholar
Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, Mcdermott DF, et al. Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab. JAMA Oncol. 2019;5(10):1411.
Article
PubMed
PubMed Central
Google Scholar
Malhotra J, Jabbour SK, Aisner J. Current state of immunotherapy for non-small cell lung cancer. Transl Lung Cancer Res. 2007;6(2):196–211.
Article
CAS
Google Scholar
Tian Y, Wang J, Wen Q, Su G, Sun Y. Immune subgroup analysis for non-small cell lung cancer may be a good choice for evaluating therapeutic efficacy and prognosis. Aging. 2021;13(9):12691–709.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. New Engl J Med. 2015;372(21):2018–28.
Article
PubMed
Google Scholar
Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, et al. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127(8):2930–40.
Article
PubMed
PubMed Central
Google Scholar
Danaher P, Warren S, Lu R, Samayoa J, Sullivan A, Pekker I, et al. Pan-cancer adaptive immune resistance as defined by the tumor inflammation signature (TIS): results from the Cancer Genome Atlas (TCGA). J Immunother Cancer. 2018;6(1):63.
Article
PubMed
PubMed Central
Google Scholar
Li X, Wang C, Zhang G, Liang M, Zhang B. AKAP2 is upregulated in ovarian cancer, and promotes growth and migration of cancer cells. Mol Med Rep. 2017;16(4):5151–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thakkar A, Aljameeli A, Thomas S, Shah GV. A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells. Endocr-Relat Cancer. 2016;23(1):1–14.
Article
CAS
PubMed
Google Scholar
Li R, Liu X, Zhou XJ, Chen X, Li JP, Yin YH, et al. Identification and validation of the prognostic value of immune-related genes in non-small cell lung cancer. Am J Transl Res. 2020;12(9):5844–65.
CAS
PubMed
PubMed Central
Google Scholar
Georgoudaki A, Prokopec KE, Boura VF, Hellqvist E, Sohn S, Östling J, et al. Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis. Cell Rep. 2016;15(9):2000–11.
Article
CAS
PubMed
Google Scholar
Jeter CR, Yang T, Wang J, Chao H, Tang DG. Concise review: NANOG in cancer stem cells and tumor development: an update and outstanding questions. Stem Cells. 2015;33(8):2381–90.
Article
CAS
PubMed
Google Scholar
Du Y, Ma C, Wang Z, Liu Z, Liu H, Wang T. Nanog, a novel prognostic marker for lung cancer. Surg Oncol. 2013;22(4):224–9.
Article
PubMed
Google Scholar
Alifano M, Souazé F, Dupouy S, Camilleri-Broët S, Younes M, Ahmed-Zaïd S, et al. Neurotensin receptor 1 determines the outcome of non-small cell lung cancer. Clin Cancer Res. 2010;16(17):4401–10.
Article
CAS
PubMed
Google Scholar
Pucci F, Rickelt S, Newton AP, Garris C, Nunes E, Evavold C, et al. PF4 promotes platelet production and lung cancer growth. Cell Rep. 2016;17(7):1764–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tang J, Zhang C, Lin J, Duan P, Long J, Zhu H. ALOX5-5-HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation. Cancer Med. 2021;10(15):5246–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou X, Jiang Y, Li Q, Huang Z, Yang H, Wei C. Aberrant ALOX5 activation correlates with HER2 status and mediates breast cancer biological activities through multiple mechanisms. Biomed Res Int. 2020;2020:1–8.
CAS
Google Scholar
He J, Yu L, Qiao Z, Yu B, Liu Y, Ren H. Genetic polymorphisms of FCGR2A, ORAI1 and CD40 are associated with risk of lung cancer. Eur J Cancer Prev. 2022;31(1):7–13.
Article
CAS
PubMed
Google Scholar
Zaki MH, Vogel P, Malireddi RKS, Body-Malapel M, Anand PK, Bertin J, et al. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell. 2011;20(5):649–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Patten DA, Wilkinson AL, O’Rourke JM, Shetty S. Prognostic value and potential immunoregulatory role of SCARF1 in hepatocellular carcinoma. Front Oncol. 2020;10: 565950.
Article
PubMed
PubMed Central
Google Scholar
Siddiqui SS, Vaill M, Do R, Khan N, Verhagen AL, Zhang W, et al. Human-specific polymorphic pseudogenization of SIGLEC12 protects against advanced cancer progression. FASEB Bioadv. 2021;3(2):69–82.
Article
CAS
PubMed
Google Scholar
Lee H, Huang C, Chen W, Tsai C, Chao Y, Liu S, et al. Transglutaminase 2 promotes migration and invasion of lung cancer cells. Oncol Res Featur Preclin Clin Cancer Ther. 2018;26(8):1175–82.
Google Scholar
Maurya NS, Kushwaha S, Chawade A, Mani A. Transcriptome profiling by combined machine learning and statistical R analysis identifies TMEM236 as a potential novel diagnostic biomarker for colorectal cancer. Sci Rep. 2021;11(1):14304.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou J, Yao QM, Li JL, Chang Y, Li T, Han WL, et al. Synergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells. Apoptosis. 2016;21(10):1179–90.
Article
CAS
PubMed
Google Scholar
Wang B, Jiang B, Li Y, Dai Y, Li P, Li L, et al. AKAP2 overexpression modulates growth plate chondrocyte functions through ERK1/2 signaling. Bone. 2021;146: 115875.
Article
CAS
PubMed
Google Scholar
Jiang HC, Chen XR, Sun HF, Nie YW. Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways. Hum Cell. 2020;33(1):175–84.
Article
CAS
PubMed
Google Scholar
Babamale AO, Chen ST. Nod-like receptors: critical intracellular sensors for host protection and cell death in microbial and parasitic infections. Int J Mol Sci. 2021;22(21):11398.
Article
CAS
PubMed
PubMed Central
Google Scholar
Takahashi K, Ehata S, Miyauchi K, Morishita Y, Miyazawa K, Miyazono K. Neurotensin receptor 1 signaling promotes pancreatic cancer progression. Mol Oncol. 2021;15(1):151–66.
Article
CAS
PubMed
Google Scholar
El-Saghire H, Michaux A, Thierens H, Baatout S. Low doses of ionizing radiation induce immune-stimulatory responses in isolated human primary monocytes. Int J Mol Med. 2013;32(6):1407–14.
Article
CAS
PubMed
Google Scholar
Li C, Cai J, Ge F, Wang G. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma. Int J Mol Med. 2018;42(4):1799–808.
CAS
PubMed
PubMed Central
Google Scholar
Chen Y, Shan Y, Lu M, Desouza N, Guo Z, Hoffman R, et al. Alox5 blockade eradicates JAK2V617F-Induced polycythemia vera in mice. Cancer Res. 2017;77(1):164–74.
Article
CAS
PubMed
Google Scholar
Yang P, Yu D, Zhou J, Zhuang S, Jiang T. TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/beta-catenin pathway. Cell Cycle. 2019;18(10):1122–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou X, Jiang Y, Li Q, Huang Z, Yang H, Wei C. Aberrant ALOX5 activation correlates with HER2 status and mediates breast cancer biological activities through multiple mechanisms. Biomed Res Int. 2020;2020:1703531.
Article
PubMed
PubMed Central
Google Scholar
Xu XS, Feng ZH, Cao D, Wu H, Wang MH, Li JZ, et al. SCARF1 promotes M2 polarization of Kupffer cells via calcium-dependent PI3K-AKT-STAT3 signalling to improve liver transplantation. Cell Prolif. 2021;54(4): e13022.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang F, Wang L, Qu C, Chen L, Geng Y, Cheng C, et al. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling. BMC Cancer. 2021;21(1):396.
Article
PubMed
PubMed Central
CAS
Google Scholar
Cheng JH, Zhang WJ, Zhu JF, Cui D, Song KD, Qiang P, et al. CaMKIIgamma regulates the viability and self-renewal of acute myeloid leukaemia stem-like cells by the Alox5/NF-kappaB pathway. Int J Lab Hematol. 2021;43(4):699–706.
Article
PubMed
Google Scholar
Novakowski KE, Huynh A, Han S, Dorrington MG, Yin C, Tu Z, et al. A naturally occurring transcript variant of MARCO reveals the SRCR domain is critical for function. Immunol Cell Biol. 2016;94(7):646–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ding X, Xu J, Wang C, Feng Q, Wang Q, Yang Y, et al. Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-kappaB activation, and promotion of cell invasion and angiogenesis. Cell Death Differ. 2019;26(10):1970–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hou Y, Xiao X, Yu W, Qi S. Propofol suppresses microglia inflammation by targeting TGM2/NF-kappaB signaling. J Immunol Res. 2021;2021:4754454.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wang XF, En-Zhou J, Li DJ, Mao CY, He Q, Zhang JF, et al. VSTM1 regulates monocyte/macrophage function via the NF-kappaB signaling pathway. Open Med (Wars). 2021;16(1):1513–24.
Article
CAS
Google Scholar
Liu Y, Duan Y, Li Y. Integrated gene expression profiling analysis reveals probable molecular mechanism and candidate biomarker in Anti-TNFalpha non-response IBD patients. J Inflamm Res. 2020;13:81–95.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang L, Yang HY, Zang CX, Shang JM, Liu H, Zhang ZH, et al. TLR2 potentiates SR-marco-mediated neuroinflammation by interacting with the SRCR domain. Mol Neurobiol. 2021;58(11):5743–55.
Article
CAS
PubMed
Google Scholar
Wu X, Xu L, Shen Y, Yu N, Zhang Y, Guo T. MALP-2, an agonist of TLR6, promotes the immune status without affecting the differentiation capacity of umbilical cord mesenchymal stem cells. Exp Ther Med. 2017;14(6):5540–6.
CAS
PubMed
PubMed Central
Google Scholar
Matsumoto K, Yasuoka H, Yoshimoto K, Suzuki K, Takeuchi T. Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis. Sci Rep. 2021;11(1):222.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Skibbe JR, Hu C, Dong L, Ferchen K, Su R, et al. ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia. Sci Rep. 2017;7(1):1853.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sadeghi B, Al-Chaqmaqchi H, Al-Hashmi S, Brodin D, Hassan Z, Abedi-Valugerdi M, et al. Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target? Bone Marrow Transplant. 2013;48(2):284–93.
Article
CAS
PubMed
Google Scholar
Normand S, Waldschmitt N, Neerincx A, Martinez-Torres RJ, Chauvin C, Couturier-Maillard A, et al. Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens. Nat Commun. 2018;9(1):5338.
Article
CAS
PubMed
PubMed Central
Google Scholar
Woods B, Chen W, Chiu S, Marinaccio C, Fu C, Gu L, et al. Activation of JAK/STAT signaling in megakaryocytes sustains myeloproliferation in vivo. Clin Cancer Res. 2019;25(19):5901–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Zheng N, Sun T, Zhao H, Chen Y, Liu C. Role of TGM2 in Tcell lymphoblastic lymphoma via regulation of IL6/JAK/STAT3 signalling. Mol Med Rep. 2022;25(3):1–9.
Article
Google Scholar
Weigert A, Strack E, Snodgrass RG, Brune B. MPGES-1 and ALOX5/-15 in tumor-associated macrophages. Cancer Metastasis Rev. 2018;37(2–3):317–34.
Article
CAS
PubMed
Google Scholar
Nimmerjahn F, Ravetch JV. Fcγ receptors as regulators of immune responses. Nat Rev Immunol. 2008;8(1):34–47.
Article
CAS
PubMed
Google Scholar
La Fleur L, Botling J, He F, Pelicano C, Zhou C, He C, et al. Targeting MARCO and IL37R on immunosuppressive macrophages in lung cancer blocks regulatory t cells and supports cytotoxic lymphocyte function. Cancer Res. 2021;81(4):956–67.
Article
CAS
PubMed
Google Scholar
Gharagozloo M, Mahmoud S, Simard C, Mahvelati TM, Amrani A, Gris D. The dual immunoregulatory function of Nlrp12 in T cell-mediated immune response: lessons from experimental autoimmune encephalomyelitis. Cells. 2018;7(9):119.
Article
CAS
PubMed Central
Google Scholar
Ramirez-Ortiz ZG, Pendergraft WR, Prasad A, Byrne MH, Iram T, Blanchette CJ, et al. The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat Immunol. 2013;14(9):917–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mitra N, Banda K, Altheide TK, Schaffer L, Johnson-Pais TL, Beuten J, et al. SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas. J Biol Chem. 2011;286(26):23003–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lai TS, Greenberg CS. Histaminylation of fibrinogen by tissue transglutaminase-2 (TGM-2): potential role in modulating inflammation. Amino Acids. 2013;45(4):857–64.
Article
CAS
PubMed
Google Scholar
Qu J, Jiang M, Wang L, Zhao D, Qin K, Wang Y, et al. Mechanism and potential predictive biomarkers of immune checkpoint inhibitors in NSCLC. Biomed Pharmacother. 2020;127: 109996.
Article
CAS
PubMed
Google Scholar
Basu B, Dean E, Puglisi M, Greystoke A, Ong M, Burke W, et al. First-in-human pharmacokinetic and pharmacodynamic study of the dual m-TORC 1/2 inhibitor AZD2014. Clin Cancer Res. 2015;21(15):3412–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Powell JD, Pollizzi KN, Heikamp EB, Horton MR. Regulation of immune responses by mTOR. Annu Rev Immunol. 2012;30(1):39–68.
Article
CAS
PubMed
Google Scholar
Albert MH, Mannert J, Fleischmann KK, Schiemann M, Pagel P, Schmid I, et al. MiRNome and transcriptome aided pathway analysis in human regulatory T cells. Genes Immun. 2014;15(5):303–12.
Article
CAS
PubMed
Google Scholar
Guichard SM, Curwen J, Bihani T, D’Cruz CM, Yates JW, Grondine M, et al. AZD2014, an inhibitor of mTORC1 and mTORC2, is highly effective in ER+ breast cancer when administered using intermittent or continuous schedules. Mol Cancer Ther. 2015;14(11):2508–18.
Article
CAS
PubMed
Google Scholar
Liao H, Huang Y, Guo B, Liang B, Liu X, Ou H, et al. Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma. Am J Cancer Res. 2015;5(1):125–39.
PubMed
Google Scholar
Axten JM, Medina JR, Feng Y, Shu A, Romeril SP, Grant SW, et al. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H -indol-5-yl)-7H -pyrrolo[2,3-d ]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem. 2012;55(16):7193–207.
Article
CAS
PubMed
Google Scholar
Rozpedek W, Pytel D, Mucha B, Leszczynska H, Diehl JA, Majsterek I. The role of the PERK/eIF2α/ATF4/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress. Curr Mol Med. 2016;16(6):533–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li J, Xu J, Li Z. Obatoclax, the pan-Bcl-2 inhibitor sensitizes hepatocellular carcinoma cells to promote the anti-tumor efficacy in combination with immune checkpoint blockade. Transl Oncol. 2021;14(8):101116.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bhati KK, Luong AM, Batoko H. VPS34 complexes in plants: untangled enough? Trends Plant Sci. 2021;26(4):303–5.
Article
CAS
PubMed
Google Scholar
Noman MZ, Parpal S, Van Moer K, Xiao M, Yu Y, Arakelian T, et al. Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy. Sci Adv. 2020;6(18):x7881.
Article
CAS
Google Scholar
Jiang J, Jin Z, Zhang Y, Peng L, Zhang Y, Zhu Z, et al. Robust prediction of immune checkpoint inhibition therapy for non-small cell lung cancer. Front Immunol. 2021;12:646874.
Article
CAS
PubMed
PubMed Central
Google Scholar